DeepSensi™ Cognitive EngineBuilt for licensed physicians.Request access

Public Benefit Charter · Precision Medicine Suites · Subsidized Allocation

Precision Suites, Patient PRO & Family Protection

University-grade consilium intelligence for patients and families facing intractable diagnostic odysseys. Sovereign cognitive software that maps the inter-specialty white space, bridges fragmented records, and delivers cryptographically sealed evidence directly to your licensed physician.

Multidisciplinary clinical consilium analyzing complex diagnostic tensors with DeepSensi Edge Node deployed on conference table.
10,000
annual subsidized cases
$790
subsidized allocation ($4,850 value)
100%
full hardship fee waiver path
Zero
markup on laboratory diagnostics
Multidisciplinary clinical consilium analyzing complex diagnostic tensors with DeepSensi.

Delaware Public Benefit Corporation · Statutory Commitment

Golden Horizon™ PBC Charter Allocation

Under our statutory charter as a Delaware Public Benefit Corporation, DeepSensi permanently allocates cognitive computing capacity to fund the difference between the standard institutional value ($4,850) and the subsidized protocol allocation ($790) for up to 10,000 cases annually.

Public benefit allocationDeepSensi PBC Public Benefit Charter

Golden Horizon™ Protocol

100% Full Hardship Fee Waiver Available

Institutional Public Benefit Allocation & Deep Subsidies for 10,000 Cases Annually Across Elite Precision Suites

$4,850 $790 / Subsidized Allocation
  • Subsidized Precision Suite Allocation: Up to 10,000 annual subsidized case intakes across 11 elite disease domains (standard value $4,850 bridged by PBC charter funds).
  • 100% Full Hardship Waiver Pathway: Complete fee waiver for families in acute financial distress, Medicaid/CHIP enrollment, or catastrophic out-of-pocket medical debt.
  • Bring-Your-Own-Diagnostics (BYOD) Rule: Pure cognitive software evaluation. Patients and collaborating physicians provide their own required laboratory panels conducted at accredited local laboratories; DeepSensi never marks up or duplicates lab tests.
  • Intractable & Chronic Illness Focus: Prioritized for patients facing complex multi-system diagnostic odysseys.
  • Autonomous Clinical Trial Matching: Global screening across Phase II/III pipelines and expanded-access protocols.
  • SIL-4 Deterministic Audit: Cryptographically sealed second opinion dossier delivered directly to your treating physician.
  • Direct Patient Sovereignty: Direct identifiers removed on device; zero cloud PHI egress.
Apply for Charter Allocation
Physician-Directed Intake · US & InternationalSingle Case Investigation

Patient PRO

Complex Case Navigation Dossier & Physician Briefing

Available by Application / Single Complex Case Investigation

Designed for patients and families trapped in prolonged diagnostic odysseys across multiple medical specialties, before a single disease domain has been established. You sponsor the cognitive synthesis privately; our engine cross-references your uploaded laboratory results (BYOD) across 60+ biological databases. The comprehensive, cryptographically sealed Clinical Decision Support dossier is delivered directly to the licensed physician you nominate. Your doctor retains complete clinical authority and independent decision-making.

  • Sponsored by Patient/Caregiver, Directed to Physician: Seamless intake workflow routing actionable medical intelligence to your doctor’s desk.
  • Bring-Your-Own-Diagnostics (BYOD) Model: Evaluates patient-provided independent laboratory tests (OAT, blood panels, stool metagenomics); zero lab markups.
  • Cross-Disciplinary Differential Deduction: Multi-specialty physiological reasoning resolving contradictions between conflicting prior diagnoses.
  • Evidence-Audited Citations: Every hypothesis is mapped to peer-reviewed literature and curated genomic databases.
  • Includes Free Physician Workbench: Your designated treating physician receives free full access to verify and co-sign the dossier.
Apply for Patient PRO
Family Multi-Case Allocation · By ApplicationFamily Shield & Longitudinal Care

Family Protection

Multi-Member Complex Case Continuity & Longitudinal Trajectory Tracking

Available by Application / Up to 4 Family Members Annually

A dedicated annual coverage framework for families managing hereditary, neurodevelopmental, or intractable chronic illnesses across multiple relatives. Enables up to 12 comprehensive case investigations per year, with each dossier delivered securely to the respective individual's licensed physician under valid medical authorization.

  • Multi-Family Coverage (Up to 4 Relatives): Structured intake for pediatric, adult, and elder family members facing complex chronic illness.
  • 12 Deep Clinical Investigations Annually: Full multi-omic biomarker tensor synthesis and longitudinal outcome tracking.
  • Cross-Family Genetic & Environmental Correlates: Identification of shared metabolic, mitochondrial, and immune patterns across relatives.
  • Strict Physician Delivery: Each relative’s analysis is dispatched solely to their own treating clinician.
  • Sovereign Encryption & Data Control: Zero commercial health-data resale; your family’s records remain under your permanent cryptographic sovereignty.
Apply for Family Protection

Diagnostic Independence & Integrity

Bring Your Own Diagnostics (BYOD)

Diagnostic objectivity requires absolute financial decoupling. DeepSensi is purely cognitive decision support software (SIL-4 CDS). We do not sell, perform, or mark up laboratory tests.

Bring your own diagnostics. Have them ready. Precision Suites™ read laboratory results you already have or obtain independently; DeepSensi never sells, duplicates or marks up a test. Each Suite lists the panels it reads, from organic acids (OAT) and stool metagenomics to therapeutic drug monitoring and blood chemistry. Where your state allows, you can order many panels yourself from an accredited direct-access laboratory; otherwise your physician orders them. When you open your Suite, your results are ready to upload, and the analysis goes to your physician.

Metabolic ProfileComprehensive Organic Acids Test (OAT), Amino Acid profile, plasma acylcarnitines
Microbiome MetagenomicsStool Metagenomics (WGS), SCFA synthesis, gut barrier permeability markers
Blood Chemistry & TDMComprehensive metabolic panel, CBC, specialized autoantibody titers, therapeutic drug monitoring
Genomic DataWhole Exome / Genome Sequencing (WES/WGS) or targeted pharmacogenomics (PGx)
Clinical patient advocate and case navigator reviewing diagnostic history and medical records with patient.

The Complete Catalog · $790 Subsidized Intake & 1-Yr Longitudinal Tracking

The 11 Precision Medicine Suites™

Each Suite provides dedicated domain reasoning, continuous trajectory modeling, and PubMed-indexed evidence synthesis. Subsidized founding protocol allocation: $790 per case (standard institutional value $4,850).

Launch October 2026Epilepsy & DEE

EPI-Precision Suite™

Pediatric & Drug-Resistant Epilepsy Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Dual-Pathway Differential Engine: Resolves contradictions in refractory seizure etiology.
  • MASAI Digital Twin Seizure Trajectory Modeling.
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Gut-Brain Axis Mapping (Neurotransmitter Precursors & Metabolites).
  • DSS-001 Cross-Verified Decision Dossier for Doctor.
  • Physician Co-Signature & Free Clinician Workbench.
Launch October 2026ASD, PANS & ME/CFS

NEURO-Precision Suite™

Neurodevelopmental & Post-Viral Syndrome Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Neuroinflammatory Multi-System Synthesis: Mapping glial activation and peripheral metabolic triggers.
  • MASAI Digital Twin Neuroinflammatory Dynamics.
  • Kynurenine/Tryptophan & Cytokine Pathway Analytics.
  • Serial ATEC & CY-BOCS Behavioral Trajectory Tracking.
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Gut-Brain Axis Mapping & Evidence Dossier.
Launch October 2026IBD, Lupus & MS

IMMUNO-Precision Suite™

Refractory Autoimmune & Mucosal Barrier Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Mucosal Barrier & Immunometabolism Modeling: Resolving treatment-resistant flares.
  • MASAI Digital Twin Mucosal Barrier Dynamics.
  • Serial Calprotectin & Autoantibody Trajectory Curves.
  • Steroid-Free Remission Optimization Protocols.
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & DSS-001 Evidence Dossier.
Launch October 2026Marrow Protection

ONCO-Precision Suite™

Chemotherapy De-Compounding & Marrow Resilience

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Supportive Marrow Sentry: Monitoring hematologic nadirs during active chemotherapy.
  • MASAI Digital Twin Bone Marrow Kinetic Curves.
  • Chemotherapy Relative Dose Intensity (RDI ≥ 85%) Sentry.
  • Pharmacokinetic Drug Interaction & Toxicity Tensor.
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & DSS-001 Evidence Dossier.
Senior specialist physician reviewing complex multi-omic laboratory panels and diagnostic dossiers in clinical consultation with patient.
Launch October 2026Mito & Inborn Errors

METABO-Precision Suite™

Mitochondrial Cytopathy & Organic Acidemia Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Bioenergetic & Anion Gap Modeling: Complex organic acidemia and respiratory chain failure.
  • Plasma Acylcarnitines (C0-C18) & Amino Acid Tensors.
  • Lactate/Pyruvate & Respiratory Chain Flux Modeling.
  • Acute Metabolic Decompensation Early-Warning Sentry.
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & DSS-001 Evidence Dossier.
Launch October 2026POTS & Cardiomyopathies

CARDIO-Precision Suite™

Autonomic Dysautonomia & Channelopathy Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Autonomic & Channelopathy Sentry: Resolving refractory orthostatic intolerance and syncope.
  • POTS Orthostatic Hemodynamics & Catecholamine Modeling.
  • Advanced Particle Lipidomics (Lp(a), ApoB, LDL-P).
  • Cardiac Ion Channel Drug-Safety Auditing (SCN5A, KCNQ1).
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & DSS-001 Evidence Dossier.
Launch October 2026Undiagnosed & Orphan N=1

RARE-Precision Suite™

Multi-System Diagnostic Odyssey Resolution Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Ultra-Rare Disease Synthesis: Breaking the multi-year diagnostic odyssey for N=1 patients.
  • Human Phenotype Ontology (HPO) Deep Graph Synthesis.
  • WGS Trio & DNA Methylation Episignature Re-Analysis.
  • ACMG VUS Pathogenic Reclassification Engine.
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & DSS-001 Evidence Dossier.
Launch October 2026Endometriosis & Gyn-Immune

ENDO-Precision Suite™

Deep Infiltrating Endometriosis & Adenomyosis Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Peritoneal & Estrobolome Modeling: Chronic pelvic pain and immuno-gnecological infertility.
  • Estrobolome Metagenomic & Peritoneal Cytokine Remodeling.
  • Surgical Avoidance & AMH Ovarian Reserve Protection Scoring.
  • EHP-30 Pelvic Central Sensitization Trajectory Tracking.
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & Free Clinician Workbench.
Dedicated clinical case navigator and patient advocate reviewing diagnostic history and personalized longitudinal care roadmap with family.
Launch October 2026Treatment-Resistant Psychiatry

MIND-Precision Suite™

Treatment-Resistant Depression & Neuro-Metabolic Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Immuno-Psychiatry & TRD Resolution: Biological root causes of refractory mood disorders.
  • Tryptophan-Kynurenine Neurotoxic Metabolite De-escalation.
  • Microglial Activation & Systemic Immuno-Biotyping (hs-CRP, IL-6).
  • Continuous Passive Wearable Biometrics (HRV, Sleep SWS Architecture).
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & Free Clinician Workbench.
Launch October 2026Psychiatric Genomics

PSYCH-Precision Suite™

Psychiatric Genomics & Pharmacogenomics Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Psychotropic Pharmacogenomics: Preventing adverse drug events and ineffective prescribing.
  • Polygenic Risk Scoring Across Psychiatric Conditions.
  • Serotonin & Dopamine Pathway Receptor Genotyping.
  • Pharmacogenomics of Psychotropic Medicines (CYP2D6, CYP2C19).
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & DSS-001 Evidence Dossier.
Launch October 2026Healthy Aging

LONGEVITY-Precision Suite™

Epigenetic Clocks & Healthy Aging Platform

$4,850 $790 / Case Intake & 1-Yr Tracking
  • Cellular Aging & Epigenetics: Deep profiling of biological vs chronological aging kinetics.
  • Epigenetic Clocks (DNA Methylation Analysis).
  • Cardiometabolic & Chronic Inflammatory Biomarkers.
  • Prescription Audit for Older Adults (AGS Beers Criteria).
  • Multi-System Biomarker Tensor (OAT, Microbiome, TDM).
  • Physician Co-Signature & DSS-001 Evidence Dossier.

For the Nominated Doctor

Physician Workbench: Always 100% Free

DeepSensi is designed to support, not bypass, the treating physician. When a patient or family enrolls in a Precision Suite or Patient PRO, their licensed doctor receives full, unrestricted access to the Clinician Workbench at zero cost.

Licensed CliniciansPhysician Workbench

Independent Verification Cockpit

Free ($0) / for the treating doctor
  • Full Evidence Audit Trail: Inspect every citation across 60+ medical databases.
  • Differential Findings Review: Independent clinical verification of cross-specialty hypotheses.
  • Complete Therapeutic Autonomy: The physician makes every decision and co-signs the care plan.
  • Direct Encrypted Case Ingestion: Seamless receipt of the patient's BYOD laboratory synthesis.
Request Clinician Access

Regulatory Notice & Future Clinical Add-ons

Transparent FDA Regulatory Positioning

Advanced autonomous diagnostic alerting and predictive clinical trajectory features require formal FDA premarket authorization. DeepSensi is preparing these modules as future add-ons; current Precision Suites function strictly within Section 520(o)(1)(E) Clinical Decision Support criteria.

Requires FDA authorizationNot available in your region yet

Treating physician in consultation explaining cryptographically sealed DeepSensi clinical decision support dossier to patient.